Do you want to read an article? Please log in or register.
Inflammatory Response in Exacerbations of COPD: Clinical and Predictive Roles of C-Reactive Protein
COPD
RECOMMENDED
Related content
COMMENTED
COPD
Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Thorax
Sadatsafavi M, Miravitlles M, Quint JK, Perugini V, Tavakoli H, Amegadzie JE, Alcazar Navarrete B, Respiratory Effectiveness Group (REG)-COPD working group
doi: 10.1136/thorax-2025-223770
COPD
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice
Semin Respir Crit Care Med
Sartori F, Sartori G, Di Chiara C, Fantin A, Crisafulli E
doi: 10.1055/a-2693-0577
RECOMMENDED
Asthma
Green Light for Response: Clinical Stratification of Response to Biologic Therapy in Severe Asthma
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Lopez-Rodríguez R, Cañas JA, Mahíllo-Fernández I, Rial MJ
doi: 10.2147/JAA.S577215
RECOMMENDED
COPD
CLINICAL PROTOCOL FOR THE USE OF BIOLOGIC THERAPY IN COPD
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Calle Rubio M, Soler-Cataluña JJ, López Campos JL, Alcázar Navarrete B, Callejas González FJ, Garín N, Bernabéu-Mora R, Cebollero Rivas P, Estrada Trigueros G, Figueira-Gonçalves JM, Fuster Gomila A, Godoy Mayoral R, López-Arranz Monge G, Marín Oto M, Márquez Martín E, de Miguel-Díez J, Riesco JA, Rodríguez García C, Santos Pérez S, Sobradillo Ecenarro P, Solé Delgado M, Miravitlles M
doi: 10.1016/j.rmed.2026.108718
Lung Cancer
Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer
Clin Lung Cancer
Cao W, Duan H, Shao C, Yan X, Liu H
doi: 10.1016/j.cllc.2025.08.004
COMMENTED
COPD
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Hammadeh BM, Younis OM, Alsufi MI, Idrees M, Hussein AM, Aldalati AY, Qtaishat FA, Qatawneh B, Bugazia A, Hamed RA
doi: 10.1177/17534666251347775
RECOMMENDED
Asthma
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Meulmeester FL, Mailhot-Larouche S, Celis-Preciado C, Lemaire-Paquette S, Ramakrishnan S, Wechsler ME, Brusselle G, Corren J, Hardy J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud A, Santoro E, Compton C, Hardin ME, Holweg CTJ, Subhashini A, Hinks TSC, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Couillard S
doi: 10.1016/S2213-2600(25)00037-2
AsthmaRespiratory Tract Infection
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register
Respir Med
Hansen S, Håkansson KEJ, Soendergaard MB, Bjerrum AS, Schmid JM, Johansson SL, Rasmussen LM, Johnsen CR, von Bülow A, Bonnesen B, Krogh NS, Hilberg O, Dongo L, Vijdea R, Ulrik CS, Porsbjerg C
doi: 10.1016/j.rmed.2025.108203
Further Publications
Patient Factors and Clinical Efficacy of Early Identification and Treatment of COPD and Asthma
Am J Respir Crit Care Med
Tardif A, Whitmore GA, Vandemheen KL, Bergeron C, Boulet LP, Côté A, McIvor RA, Penz E, Field SK, Lemière C, Mayers I, Bhutani M, Azher T, Lougheed MD, Gupta S, Ezer N, Licskai CJ, Hernandez P, Ainslie M, Alvarez GG, Mulpuru S, Aaron SD
doi: 10.1164/rccm.202505-1260OC